The	the	O	O
role	role	O	O
of	of	O	O
nitrergic	nitrergic	O	O
system	system	O	O
in	in	O	O
lidocaine-induced	lidocaine-induced	O	O
convulsion	convulsion	O	S_disease
in	in	O	O
the	the	O	O
mouse	mouse	O	O
.	.	O	O

The	the	O	O
effects	effects	O	O
of	of	O	O
N-nitro-L-arginine-methyl	n-nitro-l-arginine-methyl	O	O
ester	ester	S_chemicals	O
(	(	O	O
L-NAME	l-name	S_chemicals	O
)	)	O	O
a	a	O	O
nitric	nitric	B_chemicals	O
oxide	oxide	S_chemicals	O
(	(	O	O
NO	no	O	O
)	)	O	O
synthase	synthase	B_chemicals	O
inhibitor	inhibitor	I_chemicals	O
and	and	O	O
L-arginine	l-arginine	S_chemicals	O
,	,	O	O
a	a	O	O
NO	no	O	O
precursor	precursor	O	O
,	,	O	O
were	were	O	O
investigated	investigated	O	O
on	on	O	O
lidocaine-induced	lidocaine-induced	O	O
convulsions	convulsions	O	S_disease
.	.	O	O

In	in	O	O
the	the	O	O
first	first	O	O
experiment	experiment	O	O
,	,	O	O
four	four	O	O
groups	groups	O	O
of	of	O	O
mice	mice	O	O
received	received	O	O
physiological	physiological	O	O
saline	saline	O	O
(	(	O	O
0.9	0.9	O	O
%	%	O	O
)	)	O	O
,	,	O	O
L-arginine	l-arginine	S_chemicals	O
(	(	O	O
300	300	O	O
mg/kg	mg/kg	O	O
,	,	O	O
i.p	i.p	O	O
.	.	O	O
)	)	O	O
,	,	O	O
L-NAME	l-name	S_chemicals	O
(	(	O	O
100	100	O	O
mg/kg	mg/kg	O	O
,	,	O	O
i.p	i.p	O	O
.	.	O	O
)	)	O	O
and	and	O	O
diazepam	diazepam	S_chemicals	O
(	(	B_chemicals	O
2	2	I_chemicals	O
mg/kg	mg/kg	O	O
)	)	O	O
,	,	O	O
respectively	respectively	O	O
.	.	O	O

Thirty	thirty	O	O
minutes	minutes	O	O
after	after	O	O
these	these	O	O
injections	injections	O	O
,	,	O	O
all	all	O	O
mice	mice	O	O
received	received	O	O
lidocaine	lidocaine	S_chemicals	O
(	(	O	O
50	50	O	O
mg/kg	mg/kg	O	O
,	,	O	O
i.p	i.p	O	O
.	.	O	O
)	)	O	O
.	.	O	O

In	in	O	O
the	the	O	O
second	second	O	O
experiment	experiment	O	O
,	,	O	O
four	four	O	O
groups	groups	O	O
of	of	O	O
mice	mice	O	O
received	received	O	O
similar	similar	O	O
treatment	treatment	O	O
in	in	O	O
the	the	O	O
first	first	O	O
experiment	experiment	O	O
,	,	O	O
and	and	O	O
30	30	O	O
min	min	O	O
after	after	O	O
these	these	O	O
injections	injections	O	O
,	,	O	O
all	all	O	O
mice	mice	O	O
received	received	O	O
a	a	O	O
higher	higher	O	O
dose	dose	O	O
of	of	O	O
lidocaine	lidocaine	S_chemicals	O
(	(	O	O
80	80	O	O
mg/kg	mg/kg	O	O
)	)	O	O
.	.	O	O

L-NAME	l-name	S_chemicals	O
(	(	O	O
100	100	O	O
mg/kg	mg/kg	O	O
,	,	O	O
i.p	i.p	O	O
.	.	O	O
)	)	O	O
and	and	O	O
diazepam	diazepam	S_chemicals	O
(	(	B_chemicals	O
2	2	I_chemicals	O
mg/kg	mg/kg	O	O
)	)	O	O
significantly	significantly	O	O
decreased	decreased	O	O
the	the	O	O
incidence	incidence	O	O
of	of	O	O
lidocaine	lidocaine	S_chemicals	O
(	(	O	O
50	50	O	O
mg/kg)-induced	mg/kg)-induced	O	O
convulsions	convulsions	O	S_disease
.	.	O	O

In	in	O	O
contrast	contrast	O	O
,	,	O	O
the	the	O	O
L-arginine	l-arginine	S_chemicals	O
treatment	treatment	O	O
increased	increased	O	O
the	the	O	O
incidence	incidence	O	O
of	of	O	O
lidocaine	lidocaine	S_chemicals	O
(	(	O	O
80	80	O	O
mg/kg	mg/kg	O	O
,	,	O	O
i.p.)-induced	i.p.)-induced	O	O
convulsions	convulsions	O	S_disease
significantly	significantly	O	O
.	.	O	O

These	these	O	O
results	results	O	O
may	may	O	O
suggest	suggest	O	O
that	that	O	O
NO	no	O	O
is	is	O	O
a	a	O	O
proconvulsant	proconvulsant	O	O
mediator	mediator	O	O
in	in	O	O
lidocaine-induced	lidocaine-induced	O	O
convulsions	convulsions	O	S_disease
.	.	O	O

